Associations of HLA-DP variants with hepatitis B virus infection in southern and northern han Chinese populations: A multicenter case-control study

PLoS ONE

Volumn 6, Issue 8, 2011, Pages

  Li, Jin ^a   Yang, Daguo ^b   He, Yongwen ^a   Wang, Mengyi ^a   Wen, Zirong ^c   Liu, Lifeng ^a   Yao, Jinjian ^a   Matsuda, Koichi ^d   Nakamura, Yusuke ^d   Yu, Jinling ^a   Jiang, Xiaorui ^a   Sun, Shuzhen ^a   Liu, Qing ^a   Jiang, Xiang ^a   Song, Qilong ^a   Chen, Man ^a   Yang, Hong ^a   Tang, Feng ^a   Hu, Xiaowen ^a   Wang, Jing ^a   Chang, Ying ^a   He, Xingxing ^a   Chen, Yuan ^a   Lin, Jusheng ^a   more..

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b SHENZHEN THIRD PEOPLE S HOSPITAL   (China)

^c Qingdao Infectious Disease Hospital   (China)

^d UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CASE CONTROL STUDY; CHINESE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HEPATITIS B; HETEROZYGOTE; HLA DPA1 GENE; HLA DPB1 GENE; HUMAN; MAJOR CLINICAL STUDY; MALE; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; ASIAN; CLINICAL TRIAL; GENETICS; HAPLOTYPE; MIDDLE AGED; MULTICENTER STUDY; STATISTICAL MODEL;

HEPATITIS B VIRUS;

HLA DP ANTIGEN;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; FEMALE; HAPLOTYPES; HEPATITIS B; HLA-DP ANTIGENS; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 80052337274     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0024221     Document Type: Article

References (42)

1. World Health Organization Hepatitis B. World Health Organization Fact Sheet No. 204. Available: http://who.int/mediacentre/factsheets/fs204/en. (Revised August 2008).
2. Ganem D, Prince A, (2004) Hepatitis B virus infection-natural history and clinical consequences. New England Journal of Medicine 350: 1118.
3. Lu FM, Zhuang H, (2009) Management of hepatitis B in China. Chin Med J (Engl) 122: 3-4.
4. Wright TL, (2006) Introduction to Chronic Hepatitis B Infection. The American Journal of Gastroenterology 101: S1-S6.
5. Blackwell JM, Jamieson SE, Burgner D, (2009) HLA and Infectious Diseases. Clinical Microbiology Reviews 22: 370-385.
6. Godkin A, Davenport M, Hill AVS, (2005) Molecular analysis of HLA class II associations with hepatitis B virus clearance and vaccine nonresponsiveness. Hepatology 41: 1383-1390.
7. Thursz MR, Kwiatkowski D, Allsopp CE, Greenwood BM, Thomas HC, et al. (1995) Association between an MHC class II allele and clearance of hepatitis B virus in the Gambia. N Engl J Med 332: 1065-1069.
8. Singh R, Kaul R, Kaul A, Khan K, (2007) A comparative review of HLA associations with hepatitis B and C viral infections across global populations. WORLD JOURNAL OF GASTROENTEROLOGY 13: 1770.
9. Ahn SH, Han KH, Park JY, Lee CK, Kang SW, et al. (2000) Association between hepatitis B virus infection and HLA-DR type in Korea. Hepatology 31: 1371-1373.
10. Consortium TWTCC (2007) Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447: 661-678.
11. Ober C, Thompson E, (2005) Rethinking genetic models of asthma: the role of environmental modifiers. Current Opinion in Immunology 17: 670-678.
12. Kamatani Y, Wattanapokayakit S, Ochi H, Kawaguchi T, Takahashi A, et al. (2009) A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians. Nature Genetics 41: 591-595.
13. Zeng Z, Guan L, An P, Sun S, O'Brien SJ, et al. (2008) A population-based study to investigate host genetic factors associated with hepatitis B infection and pathogenesis in the Chinese population. BMC Infectious Diseases 8: 1.
14. He X, Chang Y, Jiang H, Tang F, Meng F, et al. (2010) Persistent Effect of IFNAR-1 Genetic Polymorphism on the Long-Term Pathogenesis of Chronic HBV Infection. Viral Immunology 23: 251-257.
15. Excoffier L, Lischer HEL, (2010) Arlequin suite ver 3.5: a new series of programs to perform population genetics analyses under Linux and Windows. Molecular Ecology Resources 10: 564-567.
16. Xu S, Yin X, Li S, Jin W, Lou H, et al. (2009) Genomic Dissection of Population Substructure of Han Chinese and Its Implication in Association Studies. The American Journal of Human Genetics 85: 762-774.
17. Guo X, Zhang Y, Li J, Ma J, Wei Z, et al. (2011) Strong influence of human leukocyte antigen (HLA)-DP gene variants on development of persistent chronic hepatitis B virus carriers in the Han Chinese population. Hepatology 53: 422-428.
18. Prieto J, (2008) Inflammation, HCC and sex: IL-6 in the centre of the triangle. Journal of Hepatology 48: 380-381.
19. Chen S, Yeh J, Chang M, Liao Y, Hsiao L, et al. (2010) Gender Difference of Alanine Aminotransferase Elevation May Be Associated with Higher Hemoglobin Levels among Male Adolescents. PLoS ONE 5: e13269.
20. Naugler W, Sakurai T, Kim S, Maeda S, Kim K, et al. (2007) Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science 317: 121.
21. Wang S-H, Yeh S-H, Lin W-H, Wang H-Y, Chen D-S, et al. (2009) Identification of androgen response elements in the enhancer I of hepatitis B virus: A mechanism for sex disparity in chronic hepatitis B. Hepatology 50: 1392-1402.
22. Trachtenberg E, Vinson M, Hayes E, Hsu YM, Houtchens K, et al. (2007) HLA class I (A, B, C) and class II (DRB1, DQA1, DQB1, DPB1) alleles and haplotypes in the Han from southern China. Tissue antigens 70: 455-463.
23. Yang G, Deng YJ, Hu SN, Wu DY, Li SB, et al. (2006) HLA-A,-B, and-DRB1 polymorphism defined by sequence-based typing of the Han population in Northern China. Tissue antigens 67: 146-152.
24. Wen B, Li H, Lu D, Song X, Zhang F, et al. (2004) Genetic evidence supports demic diffusion of Han culture. Nature 431: 302-305.
25. Zhang F, Su B, Zhang YP, Jin L, (2007) Genetic studies of human diversity in East Asia. Philos Trans R Soc Lond B Biol Sci 362: 987-995.
26. Zhao TM, Lee TD, (1989) Gm and Km allotypes in 74 Chinese populations: a hypothesis of the origin of the Chinese nation. Hum Genet 83: 101-110.
27. Chaix R, Cao C, Donnelly P, (2008) Is mate choice in humans MHC-dependent? PLoS Genet 4: e1000184.
28. Barreiro LB, Quintana-Murci L, (2010) From evolutionary genetics to human immunology: how selection shapes host defence genes. Nat Rev Genet 11: 17-30.
29. Prugnolle F, Manica A, Charpentier M, Guegan JF, Guernier V, et al. (2005) Pathogen-driven selection and worldwide HLA class I diversity. Curr Biol 15: 1022-1027.
30. Zeng G, Wang Z, Wen S, Jiang J, Wang L, et al. (2005) Geographic distribution, virologic and clinical characteristics of hepatitis B virus genotypes in China. J Viral Hepat 12: 609-617.
31. Huang ZJ, Zhou MG, Wang LJ, (2007) Study on the geographic distribution of liver cancer mortality and HBsAg carrier rate in China. Disease Surveillance (Chinese) 22: 242-245.
32. Giovanna F, Bortolotti F, Francesco D, (2008) Natural history of chronic hepatitis B: Special emphasis on disease progression and prognostic factors. Journal of Hepatology 48: 335-352.
33. Yang HI, Lu SN, Liaw YF, You SL, Sun CA, et al. (2002) Hepatitis B e antigen and the risk of hepatocellular carcinoma. N Engl J Med 347: 168-174.
34. Handunnetthi L, Ramagopalan SV, Ebers GC, Knight JC, (2009) Regulation of major histocompatibility complex class II gene expression, genetic variation and disease. Genes and Immunity 11: 99-112.
35. Llovet JM, Burroughs A, Bruix J, (2003) Hepatocellular carcinoma. Lancet 362: 1907-1917.
36. Chen JD, Yang HI, Iloeje UH, You SL, Lu SN, et al. (2010) Carriers of inactive hepatitis B virus are still at risk for hepatocellular carcinoma and liver-related death. Gastroenterology 138: 1747-1754. e1741.
37. Zhang H, Zhai Y, Hu Z, Wu C, Qian J, et al. (2010) Genome-wide association study identifies 1p36.22 as a new susceptibility locus for hepatocellular carcinoma in chronic hepatitis B virus carriers. Nat Genet 42: 755-758.
38. Thorsby E, (1974) The human major histocompatibility system. Transplant Rev 18: 51-129.
39. Pieters J, (2000) MHC class II-restricted antigen processing and presentation. Adv Immunol 75: 159-208.
40. Jones EY, Fugger L, Strominger JL, Siebold C, (2006) MHC class II proteins and disease: a structural perspective. Nat Rev Immunol 6: 271-282.
41. Grivennikov SI, Greten FR, Karin M, (2010) Immunity, Inflammation, and Cancer. Cell 140: 883-899.
42. Hirayama K, Chen H, Kikuchi M, Yin T, Gu X, et al. (1999) HLA-DR-DQ alleles and HLA-DP alleles are independently associated with susceptibility to different stages of post-schistosomal hepatic fibrosis in the Chinese population. Tissue antigens 53: 269-274.